Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Has results × venetoclax × Clear all

Phase

Status

Completed 37 Terminated 28 Active not recruiting 9 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Myeloid 1

Conditions

Myelodysplastic Syndromes 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1

Interventions

venetoclax 1 Standard of Care 1 Practice Guidelines as Topic 1 Paclitaxel 1 Decitabine 1 Brachytherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05184842 2026-01-05

Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML

Montefiore Medical Center

Phase 2 Recruiting

91 enrolled 26 charts

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡